Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

loteprednol etabonate

Known as: 17-ethoxycarbonyloxy-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate, Chloromethyl, Etabonate, Loteprednol, Chloromethyl 17 ethoxycarbonyloxy 11 hydroxy 3 oxoandrosta 1,4 diene 17 carboxylate 
The etabonate salt form of loteprednol, an ophthalmic analog of the corticosteroid prednisolone with anti-inflammatory activity. Loteprednol… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
PURPOSE To assess tear cytokine levels and clinical outcomes in moderate and severe meibomian gland dysfunction (MGD) after 2… Expand
2014
2014
Objective: The purpose of this work was to evaluate the effect of loteprednol etabonate (LE) before the initiation of topical… Expand
Highly Cited
2012
Highly Cited
2012
Topical corticosteroids are effective in reducing anterior segment inflammation but are associated with adverse drug reactions… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
2012
2012
Purpose Loteprednol etabonate (LE) is approved by the US FDA in a suspension and ointment form (0.5%) for the treatment of… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 3
Highly Cited
2008
Highly Cited
2008
The low-affinity sodium glucose cotransporter (SGLT2) plays an important role in renal glucose reabsorption and is a remarkable… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Review
2008
Review
2008
Ocular inflammatory diseases impose a significant medical and economic burden on society. Corticosteroids are potent anti… Expand
  • figure 1
Highly Cited
2004
Highly Cited
2004
PURPOSE To evaluate loteprednol etabonate ophthalmic 0.5% suspension, versus placebo for treatment of the inflammatory component… Expand
Highly Cited
1999
Highly Cited
1999
PURPOSE To compare the safety and efficacy of loteprednol etabonate 0.5% ophthalmic suspension with prednisolone acetate 1.0… Expand
Highly Cited
1997
Highly Cited
1997
PURPOSE To evaluate the efficacy and safety of loteprednol etabonate 0.5% as prophylactic treatment for the ocular signs and… Expand
Highly Cited
1993
Highly Cited
1993
The continuing development of ophthalmic steroids has resulted in compounds that have a low tendency to raise intraocular… Expand